Pixatimod
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pixatimod, covering 2025-03-07 to 2025-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC) [Phase 2]